UBS Group vs. Credit Suisse: Which Bank Stock is a Better Buy?

NYSE: UBS | UBS Group AG News, Ratings, and Charts

UBS – The financial sector is sometimes considered the bellwether of the economy. In the most recent quarter, banks did especially well, so may be time to consider banking stocks for your portfolio. UBS Group (UBS) and Credit Suisse (CS) are two top bank stocks, but which is the better buy right now? Read more to find out.

Bank stocks are taking center stage now that the top financial institutions compete for the onslaught of consumer spending. Consumers had record savings rates this past year while quarantining indoors during the pandemic.

Now that the economy is building momentum, top banks will extend loans and catalyze ongoing economic activity all the more. Perhaps the only thing that can stop the banks from raking in cash in the year ahead is a major economic recession spurred by COVID variants that breakthrough vaccine protection.

UBS Group (UBS) and Credit Suisse (CS) are two bank stocks worthy of investor attention as of the second week of August. Below, I’ll provide a look at each of these stocks to help investors make the right choice.

UBS Group (UBS)

UBS is a worldwide wealth management, asset management, universal bank, and investment bank services, provider. UBS has a forward P/E ratio of 9.32. This is a relatively low ratio that indicates UBS is underpriced at $17.05 per share. UBS has a 52-week high of $17.09. The stock has a 52-week low of $10.39. 

UBS has an overall grade of B, which translates into a Buy rating in our POWR Ratings service. UBS has a grade of A for Sentiment and Bs in the Value and Stability components. Investors can find out how UBS fares in the Growth, Momentum, and Quality components by clicking here.

Of the nearly 100 stocks in the Foreign Banks industry, UBS is ranked in the top 10, slotting in at eighth. You can find other top stocks in this industry by clicking here.

Credit Suisse (CS)

CS provides banking services, investment products, insurance, and financial advisory services in addition to pension solutions. The company’s First Boston wing offers investment research, asset management, securities underwriting, venture capital, and more. CS was in the news for all the wrong reasons this past April when it slashed its dividend and even waived bonuses following the mammoth financial loss suffered from its Archegos Capital fiasco. 

The fund’s meltdown earlier this year led to a nearly $5 billion charge taken by CS. CS has a beta of 1.39, which indicates the stock is more volatile than the market. CS has a 52-week high of $14.95, and its 52-week low is $9.28. CS has an overall grade of C and a Neutral rating in our POWR Ratings service. The stock has a grade of D in the Growth component and Cs in the Sentiment and Value components. 

You can find out how CS grades in the Momentum, Stability, and Quality component by clicking here. Out of the 98 publicly traded companies in the Foreign Banks industry, CS is ranked 71st. 

Which is the Better Buy?

UBS has the better rating in the POWR Ratings, so it is the better of these two banking stocks right now. However, CS has the potential to ascend to a higher rating in the quarters to come. In the meantime, consider adding UBS to your portfolio.


UBS shares rose $0.02 (+0.12%) in premarket trading Friday. Year-to-date, UBS has gained 21.43%, versus a 19.95% rise in the benchmark S&P 500 index during the same period.


About the Author: Patrick Ryan


Patrick Ryan has more than a dozen years of investing experience with a focus on information technology, consumer and entertainment sectors. In addition to working for StockNews, Patrick has also written for Wealth Authority and Fallon Wealth Management. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
UBSGet RatingGet RatingGet Rating
CSGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


When is the Next Bull Run for Stocks?

After the S&P 500 (SPY) made new all time highs in March it was time for a well deserved pullback in April. Now after testing key support levels stocks have bounced for 2 days. Does that mean more upside to come? Or will we be back on the “pain train”? Steve Reitmeister answers these questions in more in his updated market outlook with trading plan and preview of top stocks. Enjoy the full story below...

3 Gold Stocks to Buy Poised for Success

With expected interest rate cuts, surging gold jewelry demand, and ongoing geopolitical conflicts, gold prices have hit record highs this year. Thus, it could be wise to buy fundamentally sound gold stocks Centerra Gold (CGAU), Gold Fields (GFI), and Kinross Gold (KGC), which are well-poised for success. Keep reading…

3 Internet Stocks Poised up for Rapid Growth in April

The internet industry thrives thanks to expanding usage, its transformative impact on work and communication globally, advancements in 5G, and its widespread integration into daily life. Hence, it could be wise to consider adding internet stocks ATRenew (RERE), Chegg (CHGG), and 1-800-FLOWERS.COM (FLWS) to one’s portfolio for growth. Read on...

TXN vs. INTC Earnings Alert - Which Chip Stock Will Surge Ahead?

Growing applications of chips across diverse end-use sectors and emerging digital technologies will shape the growth trajectory of the semiconductor industry and create several opportunities for industry players. So, let’s analyze Texas Instruments (TXN) and Intel (INTC) to determine which of these chip stocks will surge following their first-quarter earnings. Read more...

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Read More Stories

More UBS Group AG (UBS) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All UBS News